Pressure modification during hepatic tumor embolization: principles, mechanism of action, and current evidence

Pressure-modifying microcatheters, including balloon and microvalve systems, alter embolic delivery during transarterial therapies by modifying downstream arterial pressure and flow dynamics. Tumor vasculature is characterized by irregular architecture, elevated interstitial pressure, and impaired autoregulation, which limit homogeneous embolic penetration and reduce tumor-to-normal liver ratio (TNR). Mechanical mechanisms such as anti-reflux protection, catheter tip centering, and improved embolisate homogenization enhance distal particle distribution. Physiologic effects include decreased downstream perfusion pressure, preferential constriction of normal hepatic arteries, intrahepatic flow redistribution, and transient pressure augmentation during infusion, facilitating deeper tumor penetration. Preclinical, computational, and clinical studies demonstrate improved embolic efficiency, tumor uptake, absorbed dose, and objective response rates in selected settings. Understanding these complementary mechanical and physiologic mechanisms may optimize patient selection and procedural strategy.